SAP controls T cell responses to virus and terminal differentiation of TH2 cells

Nature Immunology

Volumn 2, Issue 5, 2001, Pages 410-414

  Wu, Chengbin ^a   Nguyen, Khuong B ^b   Pien, Gary C ^b   Wang, Ninghai ^a   Gullo, Charles ^a   Howie, Duncan ^a   Sosa, Miriam Rodriguez ^c   Edwards, Matthew J ^d   Borrow, Persephone ^d   Satoskar, Abhay R ^c   Sharpe, Arlene H ^a   Biron, Christine A ^b   Terhorst, Cox ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; LIVER; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MOUSE; MOUSE MUTANT; SIGNAL TRANSDUCTION; SKIN LEISHMANIASIS; SPLEEN; T LYMPHOCYTE; TH2 CELL; VIROLOGY; VIRUS MENINGITIS;

ANIMALS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEISHMANIASIS, CUTANEOUS; LIVER; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, MUTANT STRAINS; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES; TH2 CELLS;

EID: 0035350808     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/87713     Document Type: Article

References (29)

1. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
2. Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet. 20, 129-135 (1998).
3. Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 95, 13765-13770 (1998).
4. Wu, C. et al. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease. Immunogenetics 31, 805-615 (2000).
5. Parolini, S. et al. X-linked Lymphoproliferative Disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill epstein-barr virus-infected cells. J. Exp. Med. 192, 337-346 (2000).
6. Tangye, S. G. et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981-6985 (1999).
7. Benoit, L., Wang, X., Pabst, H.F., Dutz, J. & Tan, R. Defective natural killer cell activation in X-linked lymphoproliferative disease. J. Immunol. 165, 3549-3553 (2000).
8. Sayos, J. et al. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol. 12, 1749-1757 (2000).
9. Sayos, J. et al. The cell surface receptors Ly-9 and CD84 recruit the XLP gene product SAP. Blood (in the press, 2001).
10. Purtilo, D.T., Grierson, H. L., Davis, J. R. & Okano, M. The X-linked lymphoproliferative disease: from autopsy coward cloning the gene 1975-1990. Pediatr. Pathol. 11, 685-710 (1991).
11. Seemayer, T.A. et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38, 471-478 (1995).
12. Maia, D. M. & Garwacki, C. P. X-linked lymphoproliferative disease: pathology and diagnosis. Pediatr. Dev. Pathol. 2, 72-77 (1999).
13. Morra, M. et al. X-linked lymphoproliferation disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19, 657-682 (2001).
14. 51Cr-release assay? J. Exp. Med. 164, 1075-1092 (1986).
15. McIntyre, K. W. & Welsh, R. M. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164, 1667-1681 (1986).
16. Yoshimoto, T. & Paul, W. E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285-1295 (1994).
17. H2 response and in immunoglobulin E production. Science 270, 1845-1847 (1995).
18. + T cells that promptly produce interleukin 4. Proc. Natl Acad. Sci. USA 92, 11931-11934 (1995).
19. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161, 6156-6163 (1998).
20. +T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549 (1997).
21. Chatelain, R., Varkila, K. & Coffman, R. L. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187 (1992).
22. Satoskar, A. R. et al. NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response. J. Immunol. 163, 5298-5302 (1999).
23. Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature 376, 260-263 (1995).
24. Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932-2936 (2000).
25. Morra, M. et al. Missense mutations that affect non-phospho tyrosine interactions and stability of the SAP SH2-domain in X-linked proliferative disease patients. J. Exp. Med. (submitted, 2001).
26. Cousens, L. P. et al. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189, 1315-1328 (1999).
27. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).
28. Pien, G. C. & Biron, C. A. Compartmental differences in NK cell responsiveness to IL-12 during lymphoeytic choriomeningitis virus infection. J. Immunol. 164, 994-1001 (2000).
29. HI response and control cutaneous Leishmania major infection. J. Immunol. 162, 6747-6754 (1999).